FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W55574842> ?p ?o ?g. }

• W55574842 endingPage "0" @default.
• W55574842 startingPage "0" @default.
• W55574842 abstract "Aliskiren in hypertension: evidence for its potential therapeutic value Doris PeterCore Medical Publishing, 445 Hamilton Avenue, Suite 1102, White Plains, New York, NY 10601, USAIntroduction: Aliskiren is the first in a new class of antihypertensive drugs that inhibits the conversion of angiotensinogen to angiotensin I by renin, thereby inhibiting production of angiotensin II, the key mediator in the regulation of body fluid volume and blood pressure. Aliskiren is currently in phase III trials as monotherapy and phase II as combination therapy in patients with mild-to-moderate hypertension, and in phase II trials in patients with diabetic nephropathy.Aims: The aim of this review is to evaluate the emerging evidence for use of aliskiren in patients with hypertension and to predict its preliminary place in therapy in clinical outcome terms. All randomized, controlled clinical trials of aliskiren (evidence level 2) were included for analysis of efficacy with the selected outcomes of blood pressure lowering, tolerability, and adherence; all other publications were excluded.Evidence review: The available level 2 evidence, although limited to phase II trials, suggests that aliskiren is effective at lowering blood pressure, an accepted surrogate outcome of morbidity and mortality, in patients with mild-to-moderate uncomplicated essential hypertension. Preliminary evidence suggests aliskiren is as effective as the angiotensin receptor blocker irbesartan, but more studies are needed. The available evidence also suggests that aliskiren is well tolerated and that patients exhibit good adherence to therapy. Aliskiren’s effect on outcomes such as all-cause mortality, reduction in cardiovascular mortality, and reduction in cardiovascular events in patients with mild-to-moderate essential hypertension as well as in special patient populations, remains to be determined. Clinical potential: The evidence available regarding aliskiren’s effect on outcomes, including blood pressure, tolerability, and adherence, supports its use in patients with mild-to-moderate hypertension. Although there is some preliminary evidence from small pilot trials, the use of aliskiren in combination with other antihypertensives, and the use of aliskiren in other patient populations, cannot be recommended without further evidence.Key words: aliskiren, hypertension, outcomes, evidence, renin, diabetic nephropathy" @default.
• W55574842 created "2016-06-24" @default.
• W55574842 creator A5019625019 @default.
• W55574842 date "2005-03-01" @default.
• W55574842 modified "2023-09-27" @default.
• W55574842 title "Aliskiren in hypertension: evidence for its potential therapeutic value" @default.
• W55574842 cites W1833111607 @default.
• W55574842 cites W1931696915 @default.
• W55574842 cites W1975504754 @default.
• W55574842 cites W1987963638 @default.
• W55574842 cites W2003209602 @default.
• W55574842 cites W2009930118 @default.
• W55574842 cites W2013354239 @default.
• W55574842 cites W2015533858 @default.
• W55574842 cites W2015569360 @default.
• W55574842 cites W2020751404 @default.
• W55574842 cites W2021645358 @default.
• W55574842 cites W2040797094 @default.
• W55574842 cites W2044773944 @default.
• W55574842 cites W2048276113 @default.
• W55574842 cites W2049397775 @default.
• W55574842 cites W2054549781 @default.
• W55574842 cites W2056064218 @default.
• W55574842 cites W2056976690 @default.
• W55574842 cites W2061170043 @default.
• W55574842 cites W2062371309 @default.
• W55574842 cites W2076822779 @default.
• W55574842 cites W2081599586 @default.
• W55574842 cites W2083507401 @default.
• W55574842 cites W2090215632 @default.
• W55574842 cites W2094412628 @default.
• W55574842 cites W2102042933 @default.
• W55574842 cites W2109547013 @default.
• W55574842 cites W2116717490 @default.
• W55574842 cites W2121490027 @default.
• W55574842 cites W2121754021 @default.
• W55574842 cites W2131494018 @default.
• W55574842 cites W2133217116 @default.
• W55574842 cites W2140812062 @default.
• W55574842 cites W2145461177 @default.
• W55574842 cites W2149620192 @default.
• W55574842 cites W2151295696 @default.
• W55574842 cites W2154743615 @default.
• W55574842 cites W2156187577 @default.
• W55574842 cites W2159770363 @default.
• W55574842 cites W2160762393 @default.
• W55574842 cites W2170912509 @default.
• W55574842 cites W2297753288 @default.
• W55574842 cites W2332457881 @default.
• W55574842 cites W2397101203 @default.
• W55574842 cites W2411414038 @default.
• W55574842 cites W2319268509 @default.
• W55574842 doi "https://doi.org/10.2147/ce.s6403" @default.
• W55574842 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3321657" @default.
• W55574842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22496673" @default.
• W55574842 hasPublicationYear "2005" @default.
• W55574842 type Work @default.
• W55574842 sameAs 55574842 @default.
• W55574842 citedByCount "0" @default.
• W55574842 crossrefType "journal-article" @default.
• W55574842 hasAuthorship W55574842A5019625019 @default.
• W55574842 hasBestOaLocation W555748421 @default.
• W55574842 hasConcept C126322002 @default.
• W55574842 hasConcept C197934379 @default.
• W55574842 hasConcept C198710026 @default.
• W55574842 hasConcept C2777387769 @default.
• W55574842 hasConcept C2778375690 @default.
• W55574842 hasConcept C2779838083 @default.
• W55574842 hasConcept C2780259554 @default.
• W55574842 hasConcept C535046627 @default.
• W55574842 hasConcept C71924100 @default.
• W55574842 hasConcept C84393581 @default.
• W55574842 hasConceptScore W55574842C126322002 @default.
• W55574842 hasConceptScore W55574842C197934379 @default.
• W55574842 hasConceptScore W55574842C198710026 @default.
• W55574842 hasConceptScore W55574842C2777387769 @default.
• W55574842 hasConceptScore W55574842C2778375690 @default.
• W55574842 hasConceptScore W55574842C2779838083 @default.
• W55574842 hasConceptScore W55574842C2780259554 @default.
• W55574842 hasConceptScore W55574842C535046627 @default.
• W55574842 hasConceptScore W55574842C71924100 @default.
• W55574842 hasConceptScore W55574842C84393581 @default.
• W55574842 hasLocation W555748421 @default.
• W55574842 hasLocation W555748422 @default.
• W55574842 hasOpenAccess W55574842 @default.
• W55574842 hasPrimaryLocation W555748421 @default.
• W55574842 hasRelatedWork W1501108898 @default.
• W55574842 hasRelatedWork W2048665589 @default.
• W55574842 hasRelatedWork W2075354764 @default.
• W55574842 hasRelatedWork W2078662350 @default.
• W55574842 hasRelatedWork W2096622096 @default.
• W55574842 hasRelatedWork W2107375710 @default.
• W55574842 hasRelatedWork W2137757612 @default.
• W55574842 hasRelatedWork W2163907191 @default.
• W55574842 hasRelatedWork W2603328895 @default.
• W55574842 hasRelatedWork W3175796942 @default.
• W55574842 hasVolume "Volume 1-Issues 1 & 2" @default.
• W55574842 isParatext "false" @default.

• next